SK

Sujata Kumari

Active Director Director DIN 10233540
DIN 10233540 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Sujata Kumari

Data last updated:

Sujata Kumari is a Director at Pharmestra Biotech Private Limited (since 2023). The company operates in Paper. Pharmestra Biotech Private Limited reported revenue of ₹9 Lakh (FY 2024).

DIN 10233540
Primary Designation Director
Industry Paper
First Appointment 10 Jul 2023
Oldest Company Age 3 yrs
Largest company Pharmestra Biotech Private Limited · ₹9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmestra Biotech Private Limited U21002DL2023PTC416849
Director10 Jul 20232023₹9 Lakh (FY 2024)Active

Board colleagues of Sujata Kumari

Directorship timeline

Open interactive timeline →
Pharmestra Biotech Private Limited
Premium access

Shareholding and investment profile for Sujata Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujata Kumari

Sujata Kumari currently holds 1 directorship: Pharmestra Biotech Private Limited (Director, since 10 Jul 2023, revenue ₹9 Lakh (FY 2024)).

Sujata Kumari was first appointed on 10 Jul 2023 as Director at Pharmestra Biotech Private Limited.

The current boards of Sujata Kumari's companies include Rajesh Kumar (Pharmestra Biotech Private Limited), Rupam Kumari (Pharmestra Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available